Lanthanum Carbonate — supply status, manufacturers & alternatives

Lanthanum Carbonate

—

🇦🇺 AUST R 106960 · Takeda Pharmaceuticals Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Marketing-authorisation holders
Active ingredient (INN)	Lanthanum Carbonate
Therapeutic category	Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Controlled substance	No

Registrations on file	6

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

10 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Excella GMBH And CO KgSymed Labs LTDMatrix Pharmacorp Private LTDNatco Pharma LTDUnimark Remedies LTDAlkem Laboratories LTD+4 more

Manufacturing countries: Germany, India, China · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

LANTHANUM CARBONATE

Cipla USA, Inc. · Oct 2025

Class IIdetails ↗

🇺🇸

LANTHANUM CARBONATE

Cipla USA, Inc. · Oct 2025

Class IIdetails ↗

🇺🇸

Lanthanum Carbonate Active Pharmaceutical Ingredient Package

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders6 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
Lanthanum carbonate	500mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Lanthanum carbonate	750mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Lanthanum carbonate	1000mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
FOSRENOL lanthanum	500mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active
FOSRENOL lanthanum	750mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active
FOSRENOL lanthanum	1000mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.